InvestorsHub Logo
Followers 35
Posts 1771
Boards Moderated 0
Alias Born 09/25/2012

Re: Spudskie post# 101516

Saturday, 09/21/2019 12:29:21 AM

Saturday, September 21, 2019 12:29:21 AM

Post# of 108192
Why did Medivation (MDVN) trade at .80 cents per share?

Why did Gilead Sciences trade below $1 per share?

Why did Pharmacyclics trade below $1 per share?

You get the point yet? just because the share price is down doesn't mean the company doesn't hold any value. All those I listed above were considered terrible investments and bad before they took off.

I can tell you right now that medivation dipped down because it failed an alzheimer's study with Dimebon, fell to about .60 cents per share and then after positive phase 2 data in prostate cancer surged. Going by your logic, everything fails. Your logic about market not impressed is flawed. Just because the market thinks one way doesn't mean you should be a follower. That's what separates the good investors from the bad ones.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News